Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Terminated 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Breast Neoplasms 272Carcinoma, Non-Small-Cell Lung 195Prostatic Neoplasms 171Stomach Neoplasms 100Lung Neoplasms 93Squamous Cell Carcinoma of Head and Neck 74Head and Neck Neoplasms 69Esophageal Neoplasms 56Neoplasms 47Neoplasm Metastasis 36Pancreatic Neoplasms 31Nasopharyngeal Carcinoma 30Ovarian Neoplasms 27Sarcoma 26Urinary Bladder Neoplasms 25Triple Negative Breast Neoplasms 20Adenocarcinoma 19Carcinoma, Squamous Cell 17Adenocarcinoma Of Esophagus 17Esophageal Squamous Cell Carcinoma 16Carcinoma, Ovarian Epithelial 15Unspecified Adult Solid Tumor, Protocol Specific 13Carcinoma, Transitional Cell 13Breast Neoplasms, Male 13Adenocarcinoma of Lung 12Salivary Gland Neoplasms 11Laryngeal Neoplasms 11Small Cell Lung Carcinoma 10Inflammatory Breast Neoplasms 10Uterine Cervical Neoplasms 9

Interventions

Docetaxel 5Gemcitabine 3Vinorelbine 2Erlotinib Hydrochloride 2Carboplatin 2surufatinib 1pemigatinib 1nimotuzumab 1lorlatinib 1Pemetrexed 1Paclitaxel 1Gene Expression Profiling 1Cisplatin 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Advanced Non-Small Cell Lung Cancer × Docetaxel × Clear all
NCT05910034 2023-06-18

Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

Fudan University

Phase 2 Not yet recruiting
132 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00345059 2016-01-14

DISTAL-2

National Cancer Institute, Naples

Phase 3 Terminated
84 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00983047 2015-08-27

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 2 Terminated
30 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00783471 2010-06-16

DOPERLO

Hellenic Cooperative Oncology Group

Phase 2 Terminated
51 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00319514 2008-03-12

Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

Gachon University Gil Medical Center

Phase 2 Completed
78 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡